Affordable Access

deepdyve-link
Publisher Website

Vesicular drug delivery systems as theranostics in COVID-19.

Authors
  • Satija, Saurabh1, 2
  • Mehta, Meenu1, 2, 3
  • Sharma, Mousmee4
  • Prasher, Parteek5
  • Gupta, Gaurav6
  • Chellappan, Dinesh K7
  • Dua, Kamal1, 3, 8, 9
  • 1 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia. , (Australia)
  • 2 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara-144411, Punjab, India. , (India)
  • 3 Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia. , (Australia)
  • 4 Department of Chemistry, Uttaranchal University, Dehradun, 248007, India. , (India)
  • 5 Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India. , (India)
  • 6 School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India. , (India)
  • 7 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia. , (Malaysia)
  • 8 School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173229, India. , (India)
  • 9 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia. , (Australia)
Type
Published Article
Journal
Future Medicinal Chemistry
Publisher
"Future Science, LTD"
Publication Date
Sep 01, 2020
Volume
12
Issue
18
Pages
1607–1609
Identifiers
DOI: 10.4155/fmc-2020-0149
PMID: 32589055
Source
Medline
Keywords
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times